| Year |
Citation |
Score |
| 2019 |
McCague AF, Raraigh KS, Pellicore MJ, Davis-Marcisak EF, Evans TA, Han ST, Lu Z, Joynt AT, Sharma N, Castellani C, Collaco JM, Corey M, Lewis MH, Penland CM, Rommens JM, et al. Correlating CFTR Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. PMID 30888834 DOI: 10.1164/Rccm.201901-0145Oc |
0.388 |
|
| 2018 |
Kim SO, Corey M, Stephenson AL, Strug LJ. Reference percentiles of FEV1 for the Canadian cystic fibrosis population: comparisons across time and countries. Thorax. PMID 29434047 DOI: 10.1136/Thoraxjnl-2017-210899 |
0.432 |
|
| 2016 |
Stern M, Bertrand DP, Bignamini E, Corey M, Dembski B, Goss CH, Pressler T, Rault G, Viviani L, Elborn JS, Castellani C. Standardy opieki Europejskiego Towarzystwa Mukowiscydozy: zarządzanie jakością w zakresie mukowiscydozy ☆ Pediatria Polska. 91. DOI: 10.1016/J.Pepo.2016.08.009 |
0.313 |
|
| 2015 |
Yau YC, Ratjen F, Tullis E, Wilcox P, Freitag A, Chilvers M, Grasemann H, Zlosnik J, Speert D, Corey M, Stanojevic S, Matukas L, Leahy TR, Shih S, Waters V. Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 262-6. PMID 25453872 DOI: 10.1016/J.Jcf.2014.09.013 |
0.394 |
|
| 2014 |
Stern M, Bertrand DP, Bignamini E, Corey M, Dembski B, Goss CH, Pressler T, Rault G, Viviani L, Elborn JS, Castellani C. European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: S43-59. PMID 24856777 DOI: 10.1016/J.Jcf.2014.03.011 |
0.378 |
|
| 2014 |
Ooi CY, Dupuis A, Gonska T, Ellis L, Ni A, Jarvi K, Martin S, Ray P, Steele L, Kortan P, Dorfman R, Solomon M, Zielenski J, Corey M, Tullis E, et al. Does integration of various ion channel measurements improve diagnostic performance in cystic fibrosis? Annals of the American Thoracic Society. 11: 562-70. PMID 24697796 DOI: 10.1513/Annalsats.201311-412Oc |
0.361 |
|
| 2014 |
Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, Tullis E, Lands LC, Coates AL, Corey M, Ratjen F. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. The European Respiratory Journal. 43: 817-23. PMID 24176992 DOI: 10.1183/09031936.00055513 |
0.401 |
|
| 2014 |
Ooi CY, Dupuis A, Ellis L, Jarvi K, Martin S, Ray PN, Steele L, Kortan P, Gonska T, Dorfman R, Solomon M, Zielenski J, Corey M, Tullis E, Durie P. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis? Thorax. 69: 254-60. PMID 24149827 DOI: 10.1136/Thoraxjnl-2013-203832 |
0.412 |
|
| 2014 |
Sosnay P, Raraigh K, Vangoor F, Yu H, Penland C, Corey M, Lewis M, Castellani C, Rommens J, Cutting G. WS13.1 Patients with mutations that permit 3% or more of wild-type CFTR function are associated with higher FEV1 Journal of Cystic Fibrosis. 13: S27. DOI: 10.1016/S1569-1993(14)60082-5 |
0.327 |
|
| 2013 |
Sosnay PR, Siklosi KR, Van Goor F, Kaniecki K, Yu H, Sharma N, Ramalho AS, Amaral MD, Dorfman R, Zielenski J, Masica DL, Karchin R, Millen L, Thomas PJ, Patrinos GP, ... Corey M, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nature Genetics. 45: 1160-7. PMID 23974870 DOI: 10.1038/Ng.2745 |
0.383 |
|
| 2012 |
Sun L, Rommens JM, Corvol H, Li W, Li X, Chiang TA, Lin F, Dorfman R, Busson PF, Parekh RV, Zelenika D, Blackman SM, Corey M, Doshi VK, Henderson L, et al. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nature Genetics. 44: 562-9. PMID 22466613 DOI: 10.1038/Ng.2221 |
0.319 |
|
| 2011 |
Wright FA, Strug LJ, Doshi VK, Commander CW, Blackman SM, Sun L, Berthiaume Y, Cutler D, Cojocaru A, Collaco JM, Corey M, Dorfman R, Goddard K, Green D, Kent JW, et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. Nature Genetics. 43: 539-46. PMID 21602797 DOI: 10.1038/Ng.838 |
0.57 |
|
| 2011 |
Sosnay PR, Castellani C, Corey M, Dorfman R, Zielenski J, Karchin R, Penland CM, Cutting GR. Evaluation of the disease liability of CFTR variants. Methods in Molecular Biology (Clifton, N.J.). 742: 355-72. PMID 21547743 DOI: 10.1007/978-1-61779-120-8_21 |
0.339 |
|
| 2011 |
Maclean JE, Solomon M, Corey M, Selvadurai H. Cystic fibrosis newborn screening does not delay the identification of cystic fibrosis in children with negative results. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: 333-7. PMID 21536503 DOI: 10.1016/J.Jcf.2011.04.002 |
0.401 |
|
| 2011 |
Taylor C, Commander CW, Collaco JM, Strug LJ, Li W, Wright FA, Webel AD, Pace RG, Stonebraker JR, Naughton K, Dorfman R, Sandford A, Blackman SM, Berthiaume Y, Paré P, ... ... Corey M, et al. A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies. Pediatric Pulmonology. 46: 857-69. PMID 21462361 DOI: 10.1002/Ppul.21456 |
0.645 |
|
| 2011 |
Leahy TR, Yau YC, Atenafu E, Corey M, Ratjen F, Waters V. Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in pediatric cystic fibrosis. Pediatric Pulmonology. 46: 489-96. PMID 21337531 DOI: 10.1002/Ppul.21383 |
0.352 |
|
| 2011 |
Park JE, Yung R, Stefanowicz D, Shumansky K, Akhabir L, Durie PR, Corey M, Zielenski J, Dorfman R, Daley D, Sandford AJ. Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection Genes and Immunity. 12: 370-377. PMID 21270830 DOI: 10.1038/Gene.2011.5 |
0.429 |
|
| 2011 |
Stephenson A, Hux J, Tullis E, Austin PC, Corey M, Ray J. Higher risk of hospitalization among females with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: 93-9. PMID 21131240 DOI: 10.1016/J.Jcf.2010.10.005 |
0.353 |
|
| 2011 |
Dorfman R, Taylor C, Lin F, Sun L, Sandford A, Paré P, Berthiaume Y, Corey M, Durie P, Zielenski J. Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis. Pediatric Pulmonology. 46: 385-92. PMID 20967843 DOI: 10.1002/Ppul.21372 |
0.619 |
|
| 2011 |
Stephenson A, Hux J, Tullis E, Austin PC, Corey M, Ray J. Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario, Canada. Pediatric Pulmonology. 46: 376-84. PMID 20967840 DOI: 10.1002/Ppul.21368 |
0.399 |
|
| 2011 |
Ooi CY, Dorfman R, Cipolli M, Gonska T, Castellani C, Keenan K, Freedman SD, Zielenski J, Berthiaume Y, Corey M, Schibli S, Tullis E, Durie PR. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 140: 153-61. PMID 20923678 DOI: 10.1053/J.Gastro.2010.09.046 |
0.416 |
|
| 2011 |
Li W, Sun L, Corey M, Zou F, Lee S, Cojocaru AL, Taylor C, Blackman SM, Stephenson A, Sandford AJ, Dorfman R, Drumm ML, Cutting GR, Knowles MR, Durie P, et al. Understanding the population structure of North American patients with cystic fibrosis. Clinical Genetics. 79: 136-46. PMID 20681990 DOI: 10.1111/J.1399-0004.2010.01502.X |
0.585 |
|
| 2010 |
Blohmke CJ, Park J, Hirschfeld AF, Victor RE, Schneiderman J, Stefanowicz D, Chilvers MA, Durie PR, Corey M, Zielenski J, Dorfman R, Sandford AJ, Daley D, Turvey SE. TLR5 as an anti-inflammatory target and modifier gene in cystic fibrosis. Journal of Immunology (Baltimore, Md. : 1950). 185: 7731-8. PMID 21068401 DOI: 10.4049/Jimmunol.1001513 |
0.392 |
|
| 2009 |
Radhakrishnan DK, Yau Y, Corey M, Richardson S, Chedore P, Jamieson F, Dell SD. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatric Pulmonology. 44: 1100-6. PMID 19830845 DOI: 10.1002/Ppul.21106 |
0.427 |
|
| 2009 |
Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M, ... ... Corey M, et al. Genetic modifiers of liver disease in cystic fibrosis. Jama. 302: 1076-83. PMID 19738092 DOI: 10.1001/Jama.2009.1295 |
0.396 |
|
| 2009 |
Dorfman R, Li W, Sun L, Lin F, Wang Y, Sandford A, Paré PD, McKay K, Kayserova H, Piskackova T, Macek M, Czerska K, Sands D, Tiddens H, Margarit S, ... ... Corey M, et al. Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results. Human Genetics. 126: 763-78. PMID 19662435 DOI: 10.1007/S00439-009-0724-8 |
0.384 |
|
| 2009 |
Rose JB, Ellis L, John B, Martin S, Gonska T, Solomon M, Tullis E, Corey M, Adeli K, Durie PR. Does the Macroduct collection system reliably define sweat chloride concentration in subjects with intermediate results? Clinical Biochemistry. 42: 1260-4. PMID 19445912 DOI: 10.1016/J.Clinbiochem.2009.05.001 |
0.327 |
|
| 2008 |
Hodson ME, Simmonds NJ, Warwick WJ, Tullis E, Castellani C, Assael B, Dodge JA, Corey M. An international/multicentre report on patients with cystic fibrosis (CF) over the age of 40 years. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 7: 537-42. PMID 18715831 DOI: 10.1016/J.Jcf.2008.06.003 |
0.397 |
|
| 2008 |
Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y, Sang R, Pereira L, Sun L, Berthiaume Y, Tsui LC, Paré PD, Durie P, Corey M, Zielenski J. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. The Journal of Clinical Investigation. 118: 1040-9. PMID 18292811 DOI: 10.1172/Jci33754 |
0.634 |
|
| 2007 |
Rohlfs RV, Taylor C, Mirea L, Bull SB, Corey M, Anderson AD. One-stage design is empirically more powerful than two-stage design for family-based genome-wide association studies. Bmc Proceedings. 1: S137. PMID 18466480 DOI: 10.1186/1753-6561-1-S1-S137 |
0.495 |
|
| 2007 |
Lands LC, Milner R, Cantin AM, Manson D, Corey M. High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial. The Journal of Pediatrics. 151: 249-54. PMID 17719932 DOI: 10.1016/J.Jpeds.2007.04.009 |
0.341 |
|
| 2007 |
Radhakrishnan DK, Corey M, Dell SD. Realities of expectorated sputum collection in the pediatric cystic fibrosis clinic. Archives of Pediatrics & Adolescent Medicine. 161: 603-6. PMID 17548767 DOI: 10.1001/Archpedi.161.6.603 |
0.387 |
|
| 2007 |
Sweezey NB, Smith D, Corey M, Ellis L, Carpenter S, Tullis DE, Durie P, O'Brodovich HM. Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis. Pediatric Pulmonology. 42: 519-24. PMID 17469152 DOI: 10.1002/Ppul.20624 |
0.431 |
|
| 2007 |
Beharry S, Ackerley C, Corey M, Kent G, Heng YM, Christensen H, Luk C, Yantiss RK, Nasser IA, Zaman M, Freedman SD, Durie PR. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. American Journal of Physiology. Gastrointestinal and Liver Physiology. 292: G839-48. PMID 17095751 DOI: 10.1152/Ajpgi.00582.2005 |
0.357 |
|
| 2007 |
Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wong Y, Sun L, Pare P, Tsui L, Durie P, Corey M, Zielenski J. 12* Modulatory effect of MBL2 on the onset of Pseudomonas aeruginosa infection is influenced by the TGFβ1 variants in pediatric CF patients Journal of Cystic Fibrosis. 6: S3. DOI: 10.1016/S1569-1993(07)60012-5 |
0.388 |
|
| 2006 |
Sontag MK, Corey M, Hokanson JE, Marshall JA, Sommer SS, Zerbe GO, Accurso FJ. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening. The Journal of Pediatrics. 149: 650-657. PMID 17095337 DOI: 10.1016/J.Jpeds.2006.07.026 |
0.349 |
|
| 2006 |
Stephenson A, Jamal S, Dowdell T, Pearce D, Corey M, Tullis E. Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density. Chest. 130: 539-44. PMID 16899856 DOI: 10.1378/Chest.130.2.539 |
0.32 |
|
| 2006 |
Taylor L, Corey M, Mallow A, Sweezey NB, Ratjen F. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis Pediatric Pulmonology. 41: 839-843. PMID 16850448 DOI: 10.1002/Ppul.20451 |
0.441 |
|
| 2006 |
Wilschanski M, Dupuis A, Ellis L, Jarvi K, Zielenski J, Tullis E, Martin S, Corey M, Tsui LC, Durie P. Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials. American Journal of Respiratory and Critical Care Medicine. 174: 787-94. PMID 16840743 DOI: 10.1164/Rccm.200509-1377Oc |
0.37 |
|
| 2006 |
Schibli S, Corey M, Gaskin KJ, Ellis L, Durie PR. Towards the ideal quantitative pancreatic function test: analysis of test variables that influence validity. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 4: 90-7. PMID 16431310 DOI: 10.1016/S1542-3565(05)00852-9 |
0.314 |
|
| 2006 |
Taylor C, Corey M, Zielenski J, Breaton J, Rousseau R, VanSpall M, Christofi M, Frangolias D, Dorfman R, Sang R, Sandford A, Pare P, Durie P. Phenotype Definition for the Analysis of Modifier Genes in Cystic Fibrosis American Journal of Epidemiology. 163. DOI: 10.1093/Aje/163.Suppl_11.S128-D |
0.583 |
|
| 2006 |
Bhattacharjee R, Schibli S, Rose J, Tulhs E, Durie P, Ellis L, Kovesi T, Corey M. 260 The natural history of liver disease in Cystic Fibrosis Journal of Cystic Fibrosis. 5. DOI: 10.1016/S1569-1993(06)80237-7 |
0.329 |
|
| 2006 |
Schibli S, Rose J, Durie P, Ellis L, Tullis E, Kovesi T, Corey M. 259 Liver disease in Cystic Fibrosis — prevalence and predisposing factors Journal of Cystic Fibrosis. 5. DOI: 10.1016/S1569-1993(06)80236-5 |
0.322 |
|
| 2006 |
Dorfman R, Sandford A, Corey M, Lin F, Wang V, Yuan X, Huang Q, Markiewicz D, Mukerjee G, Master A, Taylor C, Frangolias D, Sun L, Pare P, Durie P, et al. 15 Analysis of candidate genes as modifiers of Cystic Fibrosis Journal of Cystic Fibrosis. 5: S4. DOI: 10.1016/S1569-1993(06)80016-0 |
0.362 |
|
| 2005 |
Xu W, Taylor C, Veenstra J, Bull SB, Corey M, Greenwood CM. Recursive partitioning models for linkage in COGA data. Bmc Genetics. 6: S38. PMID 16451648 DOI: 10.1186/1471-2156-6-S1-S38 |
0.519 |
|
| 2005 |
Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, et al. Genetic modifiers of lung disease in cystic fibrosis. The New England Journal of Medicine. 353: 1443-53. PMID 16207846 DOI: 10.1056/Nejmoa051469 |
0.434 |
|
| 2005 |
Bishop MD, Freedman SD, Zielenski J, Ahmed N, Dupuis A, Martin S, Ellis L, Shea J, Hopper I, Corey M, Kortan P, Haber G, Ross C, Tzountzouris J, Steele L, et al. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Human Genetics. 118: 372-81. PMID 16193325 DOI: 10.1007/S00439-005-0059-Z |
0.425 |
|
| 2005 |
Schneiderman-Walker J, Wilkes DL, Strug L, Lands LC, Pollock SL, Selvadurai HC, Hay J, Coates AL, Corey M. Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis. The Journal of Pediatrics. 147: 321-6. PMID 16182669 DOI: 10.1016/J.Jpeds.2005.03.043 |
0.384 |
|
| 2005 |
Kalnins D, Corey M, Ellis L, Durie PR, Pencharz PB. Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis. The Journal of Pediatrics. 146: 489-93. PMID 15812451 DOI: 10.1016/J.Jpeds.2004.10.063 |
0.326 |
|
| 2005 |
Stephenson A, Brotherwood M, Robert R, Durie P, Verjee Z, Chaparro C, Corey M, Tullis E. Increased vitamin A and E levels in adult cystic fibrosis patients after lung transplantation. Transplantation. 79: 613-5. PMID 15753854 DOI: 10.1097/01.Tp.0000151660.69796.10 |
0.318 |
|
| 2005 |
Newbold ME, Tullis E, Corey M, Ross B, Brooks D. The Flutter Device versus the PEP Mask in the Treatment of Adults with Cystic Fibrosis Physiotherapy Canada. 57: 199-207. DOI: 10.3138/Ptc.57.3.199 |
0.363 |
|
| 2004 |
Katz SL, Strug LJ, Coates AL, Corey M. Disease severity in siblings with cystic fibrosis. Pediatric Pulmonology. 37: 407-12. PMID 15095323 DOI: 10.1002/Ppul.20007 |
0.394 |
|
| 2004 |
Stanbrook MB, Corey M, Tullis DE. The repeatability of forced expiratory volume measurements in adults with cystic fibrosis. Chest. 125: 150-5. PMID 14718434 DOI: 10.1378/Chest.125.1.150 |
0.386 |
|
| 2003 |
Stein R, Selvadurai H, Coates A, Wilkes DL, Schneiderman-Walker J, Corey M. Determination of maximal voluntary ventilation in children with cystic fibrosis. Pediatric Pulmonology. 35: 467-71. PMID 12746945 DOI: 10.1002/Ppul.10298 |
0.375 |
|
| 2003 |
Frangolias DD, Ruan J, Wilcox PJ, Davidson AG, Wong LT, Berthiaume Y, Hennessey R, Freitag A, Pedder L, Corey M, Sweezey N, Zielenski J, Tullis E, Sandford AJ. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease. American Journal of Respiratory Cell and Molecular Biology. 29: 390-6. PMID 12689922 DOI: 10.1165/Rcmb.2002-0271Oc |
0.389 |
|
| 2003 |
Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, Pencharz P, Durie P, Sweezey NB. Glucose intolerance in children with cystic fibrosis. The Journal of Pediatrics. 142: 128-32. PMID 12584532 DOI: 10.1067/Mpd.2003.5 |
0.384 |
|
| 2003 |
Gutierrez C, Dupuis A, Chaparro C, Tullis E, Singer L, Waddell T, Hutcheon M, Keshavjee S, Corey M. Survival benefit of lung transplantation in cystic fibrosis patients infected with B. Cepacia The Journal of Heart and Lung Transplantation. 22: S93. DOI: 10.1016/S1053-2498(02)00735-0 |
0.345 |
|
| 2002 |
Haston CK, Corey M, Tsui LC. Mapping of genetic factors influencing the weight of cystic fibrosis knockout mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 13: 614-8. PMID 12461646 DOI: 10.1007/S00335-002-2195-2 |
0.357 |
|
| 2002 |
Haston CK, McKerlie C, Newbigging S, Corey M, Rozmahel R, Tsui LC. Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 13: 605-13. PMID 12461645 DOI: 10.1007/S00335-002-2190-7 |
0.408 |
|
| 2002 |
Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology. 123: 1857-64. PMID 12454843 DOI: 10.1053/Gast.2002.37042 |
0.405 |
|
| 2002 |
Alothman GA, Alsaadi MM, Ho BL, Ho SL, Dupuis A, Corey M, Coates AL. Evaluation of bronchial constriction in children with cystic fibrosis after inhaling two different preparations of tobramycin. Chest. 122: 930-4. PMID 12226034 DOI: 10.1378/Chest.122.3.930 |
0.377 |
|
| 2002 |
Ip WF, Dupuis A, Ellis L, Beharry S, Morrison J, Stormon MO, Corey M, Rommens JM, Durie PR. Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome. The Journal of Pediatrics. 141: 259-65. PMID 12183724 DOI: 10.1067/Mpd.2002.125849 |
0.344 |
|
| 2002 |
Beharry S, Ellis L, Corey M, Marcon M, Durie P. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? The Journal of Pediatrics. 141: 84-90. PMID 12091856 DOI: 10.1067/Mpd.2002.124829 |
0.318 |
|
| 2002 |
Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerging Infectious Diseases. 8: 181-7. PMID 11897071 DOI: 10.3201/Eid0802.010163 |
0.348 |
|
| 2001 |
Wagener JS, Farrell PM, Corey M. A debate on why my state (province) should or should not conduct newborn screening for cystic fibrosis (14th Annual North American Cystic Fibrosis Conference). Pediatric Pulmonology. 32: 385-96. PMID 11596164 DOI: 10.1002/Ppul.1148 |
0.347 |
|
| 2001 |
Wilson DC, Rashid M, Durie PR, Tsang A, Kalnins D, Andrew M, Corey M, Shin J, Tullis E, Pencharz PB. Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination. The Journal of Pediatrics. 138: 851-5. PMID 11391328 DOI: 10.1067/Mpd.2001.113633 |
0.305 |
|
| 2000 |
Ginzberg H, Shin J, Ellis L, Goobie S, Morrison J, Corey M, Durie PR, Rommens JM. Segregation Analysis in Shwachman-Diamond Syndrome: Evidence for Recessive Inheritance American Journal of Human Genetics. 66: 1413-1416. PMID 10739765 DOI: 10.1086/302856 |
0.304 |
|
| 1999 |
Ginzberg H, Shin J, Ellis L, Morrison J, Ip W, Dror Y, Freedman M, Heitlinger LA, Belt MA, Corey M, Rommens JM, Durie PR. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. The Journal of Pediatrics. 135: 81-88. PMID 10393609 DOI: 10.1016/S0022-3476(99)70332-X |
0.358 |
|
| 1999 |
Lai HC, Corey M, FitzSimmons S, Kosorok MR, Farrell PM. Comparison of growth status of patients with cystic fibrosis between the United States and Canada. The American Journal of Clinical Nutrition. 69: 531-8. PMID 10075341 DOI: 10.1093/Ajcn/69.3.531 |
0.396 |
|
| 1998 |
Johansen HK, Kovesi TA, Koch C, Corey M, Høiby N, Levison H. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen. Pediatric Pulmonology. 26: 89-96. PMID 9727758 DOI: 10.1002/(Sici)1099-0496(199808)26:2<89::Aid-Ppul3>3.0.Co;2-C |
0.449 |
|
| 1998 |
Wilson DC, Ellis L, Zielenski J, Corey M, Ip WF, Tsui L, Tullis E, Knowles MR, Durie PR. Uncertainty in the diagnosis of cystic fibrosis: Possible role of in vivo nasal potential difference measurements ☆ ☆☆ ★ The Journal of Pediatrics. 132: 596-599. PMID 9580755 DOI: 10.1016/S0022-3476(98)70345-2 |
0.411 |
|
| 1998 |
Ellis L, Kalnins D, Corey M, Brennan J, Pencharz P, Durie P. Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study. The Journal of Pediatrics. 132: 270-6. PMID 9506640 DOI: 10.1016/S0022-3476(98)70444-5 |
0.304 |
|
| 1997 |
Corey M, Edwards L, Levison H, Knowles M. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. The Journal of Pediatrics. 131: 809-14. PMID 9427882 DOI: 10.1016/S0022-3476(97)70025-8 |
0.44 |
|
| 1997 |
Kerem E, Nissim-Rafinia M, Argaman Z, Augarten A, Bentur L, Klar A, Yahav Y, Szeinberg A, Hiba O, Branski D, Corey M, Kerem B. A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype. Pediatrics. 100: E5. PMID 9271620 DOI: 10.1542/Peds.100.3.E5 |
0.347 |
|
| 1997 |
Durno C, Corey M, Tullis E, Tsui LC, Zielenski J, Durie P. Retrospective Analysis Of Pancreatic Sufficient Patients With Cystic Fibrosis With And Without Pancreatitis: 60 Journal of Pediatric Gastroenterology and Nutrition. 25: 457. DOI: 10.1097/00005176-199710000-00077 |
0.37 |
|
| 1996 |
Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989 American Journal of Epidemiology. 143: 1007-1017. PMID 8629607 DOI: 10.1093/Oxfordjournals.Aje.A008664 |
0.384 |
|
| 1996 |
Wilschanski M, Corey M, Durie P, Tullis E, Bain J, Asch M, Ginzburg B, Jarvi K, Buckspan M, Hartwick W. Diversity of Reproductive Tract Abnormalities in Men With Cystic Fibrosis Jama. 276: 607-608. DOI: 10.1001/Jama.1996.03540080029022 |
0.411 |
|
| 1995 |
Neglia JP, FitzSimmons SC, Maisonneuve P, Schoni MH, Schoni-Affolter F, Corey M, Lowenfels AB, Boyle P, Dozor AJ, Durie P. The risk of cancer among patients with cystic fibrosis New England Journal of Medicine. 332: 494-499. PMID 7830730 DOI: 10.1056/Nejm199502233320803 |
0.361 |
|
| 1995 |
Zielenski J, Markiewicz D, Chen HS, Schappert K, Seller A, Durie P, Corey M, Tsui L. Identification of six mutations (R31L, 441delA, 681delC, 1461ins4, W1089R, E1104X) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene Human Mutation. 5: 43-47. PMID 7537150 DOI: 10.1002/Humu.1380050106 |
0.38 |
|
| 1995 |
Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. The Journal of Pediatrics. 127: 705-10. PMID 7472820 DOI: 10.1016/S0022-3476(95)70157-5 |
0.339 |
|
| 1995 |
Wilson DC, Durie PR, Ellis L, Corey M, Knowles MR, Tsui L-, Tullis E, Ip W, Levison H, Zielenski J. PATIENTS PREVIOUSLY DIAGNOSED WITH CYSTIC FIBROSIS Journal of Pediatric Gastroenterology and Nutrition. 21: 359. DOI: 10.1097/00005176-199510000-00151 |
0.446 |
|
| 1995 |
Durie PR, Ellis L, Corey M, Knowles, Tsui LC, Zielenski J, Tullis E, Ip W. Nasal Transepithelial Potential Difference In Patients With Defined Cftr Gene Mutations Journal of Pediatric Gastroenterology and Nutrition. 21: 359. DOI: 10.1097/00005176-199510000-00150 |
0.33 |
|
| 1995 |
Wilschanski M, Chait P, Wade JA, Davis L, Corey M, Louis PS, Griffiths AM, Blendis LM, Moroz SP, Scully L, Roberts EA. Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis Hepatology. 22: 1415-1422. DOI: 10.1002/Hep.1840220513 |
0.353 |
|
| 1992 |
Couper RTL, Corey M, Moore DJ, Fisher LJ, Forstner GG, Durie PR. Decline of exocrine pancreatic function in cystic fibrosis patients with pancreatic sufficiency. Pediatric Research. 32: 179-182. PMID 1508606 DOI: 10.1203/00006450-199208000-00011 |
0.37 |
|
| 1992 |
Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. The New England Journal of Medicine. 326: 1187-91. PMID 1285737 DOI: 10.1056/Nejm199204303261804 |
0.38 |
|
| 1991 |
Fried MD, Durie PR, Tsui LC, Corey M, Levison H, Pencharz PB. The cystic fibrosis gene and resting energy expenditure. The Journal of Pediatrics. 119: 913-6. PMID 1960606 DOI: 10.1016/S0022-3476(05)83042-2 |
0.367 |
|
| 1991 |
Leiberman A, Cole P, Corey M, Forte V, Levison H. Otolaryngological and Rhinomanometric Findings in Cystic Fibrosis American Journal of Rhinology. 5: 61-65. DOI: 10.2500/105065891782112888 |
0.449 |
|
| 1990 |
Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, Tsui LC, Durie P. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). The New England Journal of Medicine. 323: 1517-22. PMID 2233932 DOI: 10.1056/Nejm199011293232203 |
0.444 |
|
| 1990 |
Koletzko S, Corey M, Ellis L, Spino M, Stringer DA, Durie PR. Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome. The Journal of Pediatrics. 117: 815-822. PMID 2231217 DOI: 10.1016/S0022-3476(05)83350-5 |
0.346 |
|
| 1990 |
Kerem E, Corey M, Stein R, Gold R, Levison H. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients. The Pediatric Infectious Disease Journal. 9: 494-8. PMID 2115157 DOI: 10.1097/00006454-199007000-00008 |
0.382 |
|
| 1990 |
Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. The Journal of Pediatrics. 116: 714-9. PMID 2109790 DOI: 10.1016/S0022-3476(05)82653-8 |
0.403 |
|
| 1990 |
Durie P, Tsui L, Corey M, Kerem E, Kerem B, Romunens J, Levison H. GASTROINTESTINAL MANIFESTATIONS OF CF PATIENTS CARRYING THE Δ F5O8 MUTATION Pediatric Research. 27: 542-542. DOI: 10.1203/00006450-199005000-00101 |
0.437 |
|
| 1989 |
Corey M, Durie P, Moore D, Forstner G, Levison H. Familial concordance of pancreatic function in cystic fibrosis. The Journal of Pediatrics. 115: 274-7. PMID 2754556 DOI: 10.1016/S0022-3476(89)80082-4 |
0.398 |
|
| 1989 |
Kerem E, Corey M, Kerem B, Durie P, Tsui LC, Levison H. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. The Journal of Pediatrics. 114: 767-73. PMID 2715890 DOI: 10.1016/S0022-3476(89)80134-9 |
0.442 |
|
| 1989 |
MacLusky IB, Gold R, Corey M, Levison H. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatric Pulmonology. 7: 42-8. PMID 2505216 DOI: 10.1002/Ppul.1950070110 |
0.397 |
|
| 1988 |
Kopelman H, Corey M, Gaskin K, Durie P, Weizman Z, Forstner G. Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreas Gastroenterology. 95: 349-355. PMID 3391365 DOI: 10.1016/0016-5085(88)90490-8 |
0.363 |
|
| 1988 |
Feanny S, Forsyth S, Corey M, Levison H, Zimmerman B. Allergic bronchopulmonary aspergillosis in cystic fibrosis: a secretory immune response to a colonizing organism. Annals of Allergy. 60: 64-8. PMID 3337398 |
0.317 |
|
| 1988 |
Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. Journal of Clinical Epidemiology. 41: 583-91. PMID 3260274 DOI: 10.1016/0895-4356(88)90063-7 |
0.329 |
|
| 1988 |
Pencharz P, Berall G, Vaisman N, Corey M, Canny G. ENERGY EXPENDITURE IN CHILDREN WITH CYSTIC FIBROSIS The Lancet. 332: 513-514. PMID 2900439 DOI: 10.1016/S0140-6736(88)90163-8 |
0.311 |
|
| 1987 |
Vaisman N, Pencharz PB, Corey M, Canny GJ, Hahn E. Energy expenditure of patients with cystic fibrosis The Journal of Pediatrics. 111: 496-500. PMID 3655979 DOI: 10.1016/S0022-3476(87)80107-5 |
0.407 |
|
| 1987 |
Simmons RJ, Corey M, Cowen L, Keenan N, Robertson J, Levison H. Behavioral adjustment of latency age children with cystic fibrosis. Psychosomatic Medicine. 49: 291-301. PMID 3602299 DOI: 10.1097/00006842-198705000-00008 |
0.31 |
|
| 1987 |
Gold R, Carpenter S, Heurter H, Corey M, Levison H. Randomized trial of ceftazidime versus placebo in the management of acute respiratory exacerbations in patients with cystic fibrosis. The Journal of Pediatrics. 111: 907-13. PMID 3316565 DOI: 10.1016/S0022-3476(87)80217-2 |
0.39 |
|
| 1987 |
Wang EEL, Manson B, Corey M, Bernard K, Prober CG. False positivity of Legionella serology in patients with cystic fibrosis Pediatric Infectious Disease Journal. 6: 256-259. PMID 3106925 DOI: 10.1097/00006454-198703000-00009 |
0.395 |
|
| 1986 |
Marcotte JE, Canny GJ, Grisdale R, Desmond K, Corey M, Zinman R, Levison H, Coates AL. Effects of nutritional status on exercise performance in advanced cystic fibrosis. Chest. 90: 375-9. PMID 3743150 DOI: 10.1378/Chest.90.3.375 |
0.342 |
|
| 1986 |
Rush PJ, Shore A, Coblentz C, Wilmot D, Corey M, Levison H. The musculoskeletal manifestations of cystic fibrosis. Seminars in Arthritis and Rheumatism. 15: 213-25. PMID 3515562 DOI: 10.1016/0049-0172(86)90018-1 |
0.408 |
|
| 1986 |
Levy L, Durie P, Pencharz P, Corey M. Prognostic factors associated with patient survival during nutritional rehabilitation in malnourished children and adolescents with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 5: 97-102. PMID 3080581 DOI: 10.1097/00005176-198601000-00018 |
0.388 |
|
| 1985 |
Simmons RJ, Corey M, Cowen L, Keenan N, Robertson J, Levison H. Emotional adjustment of early adolescents with cystic fibrosis. Psychosomatic Medicine. 47: 111-22. PMID 4048358 DOI: 10.1097/00006842-198503000-00002 |
0.312 |
|
| 1985 |
Cleghorn G, Benjamin L, Corey M, Forstner G, Dati F, Durie P. Age-Related Alterations in Immunoreactive Pancreatic Lipase and Cationic Trypsinogen in Young-Children with Cystic-Fibrosis The Journal of Pediatrics. 107: 377-381. PMID 4032133 DOI: 10.1016/S0022-3476(85)80510-2 |
0.393 |
|
| 1985 |
Cowen L, Corey M, Keenan N, Simmons R, Arndt E, Levison H. Family adaptation and psychosocial adjustment to cystic fibrosis in the preschool child. Social Science & Medicine (1982). 20: 553-60. PMID 4001981 DOI: 10.1016/0277-9536(85)90393-4 |
0.365 |
|
| 1985 |
Patients CF, Levy L, Pencharz P, Durie P, Corey M. 690 LONGTERM GASTROSTOMY FEEDING IN MALNOURISHED Pediatric Research. 19: 225A-225A. DOI: 10.1203/00006450-198504000-00720 |
0.392 |
|
| 1985 |
Levy L, Pencharz P, Durie P, Corey M. 689 PROGNOSTIC FACTORS ASSOCIATED WITH SURVIVAL DURING REFEEDING IN MALNOURISHED CYSTIC FIBROSIS PATIENTS Pediatric Research. 19: 225A-225A. DOI: 10.1203/00006450-198504000-00719 |
0.356 |
|
| 1984 |
Wang EE, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. The New England Journal of Medicine. 311: 1653-8. PMID 6504106 DOI: 10.1056/Nejm198412273112602 |
0.364 |
|
| 1984 |
Corey M, Gaskin K, Durie P, Levison H, Forstner G. Improved prognosis in CF patients with normal fat absorption Journal of Pediatric Gastroenterology and Nutrition. 3: 99-105. PMID 6502398 DOI: 10.1097/00005176-198400031-00016 |
0.458 |
|
| 1984 |
Durie PR, Gaskin KJ, Corey M, Kopelman H, Weizman Z, Forstner GG. Pancreatic function testing in cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 3. PMID 6502397 DOI: 10.1097/00005176-198400031-00015 |
0.362 |
|
| 1984 |
Cowen L, Corey M, Simmons R, Keenan N, Robertson J, Levison H. Growing older with cystic fibrosis: psychologic adjustment of patients more than 16 years old. Psychosomatic Medicine. 46: 363-76. PMID 6484102 DOI: 10.1097/00006842-198407000-00005 |
0.354 |
|
| 1984 |
Corey M, Allison L, Prober C, Levison H. Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981 Journal of Infectious Diseases. 149: 283. PMID 6421945 DOI: 10.1093/Infdis/149.2.283 |
0.37 |
|
| 1984 |
Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. The Journal of Pediatrics. 104: 206-10. PMID 6420530 DOI: 10.1016/S0022-3476(84)80993-2 |
0.374 |
|
| 1984 |
Wang E, Prober C, Manson B, Corey M, Levison H. ASSOCIATION OF RESPIRATORY VIRAL INFECTIONS WITH PULMONARY DETERIORATION IN PATIENTS WITH CYSTIC FIBROSIS (CF) Pediatric Research. 18: 188A-188A. DOI: 10.1203/00006450-198404001-00572 |
0.416 |
|
| 1982 |
Gaskin KJ, Durie PR, Corey M, Wei P, Forstner GG. Evidence for a primary defect of pancreatic HCO<inf>3</inf>- secretion in cystic fibrosis Pediatric Research. 16: 554-557. PMID 7110775 DOI: 10.1203/00006450-198207000-00012 |
0.409 |
|
| 1982 |
Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. The Journal of Pediatrics. 100: 857-62. PMID 7086584 DOI: 10.1016/S0022-3476(82)80501-5 |
0.422 |
|
| 1982 |
Nolan G, McIvor P, Levison H, Fleming PC, Corey M, Gold R. Antibiotic prophylaxis in cystic fibrosis: Inhaled cephaloridine as an adjunct to oral cloxacillin The Journal of Pediatrics. 101: 626-630. PMID 6981695 DOI: 10.1016/S0022-3476(82)80726-9 |
0.38 |
|
| 1981 |
Nolan G, Mcivor P, Gold R, Newth C, Levison H, Corey M. 1052 INHALED CEPHALORIDINE IN THE TREATMENT OF CYSTIC FIBROSIS (CF) Pediatric Research. 15: 618-618. DOI: 10.1203/00006450-198104001-01078 |
0.441 |
|
| 1980 |
Gurwitz D, Corey M, Levison H. Pulmonary function and bronchial reactivity in children after croup American Review of Respiratory Disease. 122: 95-99. PMID 7406345 DOI: 10.1164/Arrd.1980.122.1.95 |
0.329 |
|
| 1980 |
Kattan M, Mansell A, Levison H, Corey M, Krastins IRB. Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis Thorax. 35: 531-535. PMID 6449095 DOI: 10.1136/Thx.35.7.531 |
0.319 |
|
| 1979 |
Koheil A, Corey M, Forstner G. Deficiency of serum carboxypeptidase B-like (anaphylatoxin inactivator, carboxypeptidase N) activity in sera from patients with cystic fibrosis Clinical and Investigative Medicine. 2: 99-103. PMID 533638 |
0.301 |
|
| 1979 |
Gurwitz D, Corey M, Francis PWJ, Crozier D, Levison H. Perspectives in cystic fibrosis Pediatric Clinics of North America. 26: 603-615. PMID 492796 DOI: 10.1016/S0031-3955(16)33752-X |
0.408 |
|
| 1978 |
Davidson GP, Hassel FM, Crozier D, Corey M, Forstner GG. Iatrogenic hyperuricemia in children with cystic fibrosis Journal of Pediatrics. 93: 976-978. PMID 722445 DOI: 10.1016/S0022-3476(78)81225-6 |
0.374 |
|
| 1978 |
Mitchell I, Corey M, Woenne R, Krastins IR, Levison H. Bronchial hyperreactivity in cystic fibrosis and asthma Journal of Pediatrics. 93: 744-748. PMID 712474 DOI: 10.1016/S0022-3476(78)81070-1 |
0.356 |
|
| 1976 |
Corey M, Levison H, Crozier D. Five to seven year course of pulmonary function in cystic fibrosis American Review of Respiratory Disease. 114: 1085-1092. PMID 1008344 DOI: 10.1164/Arrd.1976.114.6.1085 |
0.351 |
|
| Show low-probability matches. |